Pfizer concludes coronavirus vaccine trial and will seek FDA approval

Paul Offit of the Perelman School of Medicine weighed in on Pfizer’s COVID-19 vaccine. “I think there is every reason to be enormously optimistic,” he said.

・ From WBUR Radio (Boston)